BEIGENE, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 153.9 USD | -1.65% |
|
+10.76% | -14.65% |
| Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
| Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BEIGENE, LTD. | Bio Therapeutic Drugs | -1.65% | +10.76% | -14.65% | -39.62% | +23.92% | 16.09B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BGNE Stock
- Charts BeiGene, Ltd.
- Comparison Chart
